Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease Insights From the j-Cypher Registry

被引:78
|
作者
Toyofuku, Mamoru [4 ]
Kimura, Takeshi [1 ]
Morimoto, Takeshi [2 ,3 ]
Hayashi, Yasuhiko [4 ]
Ueda, Hiroaki [4 ]
Kawai, Kazuya [8 ]
Nozaki, Yoichi [7 ]
Hiramatsu, Shinichi [6 ]
Miura, Akira [5 ]
Yokoi, Yoshiaki [13 ]
Toyoshima, Shinichiro [12 ]
Nakashima, Hitoshi [11 ]
Haze, Kazuo [10 ]
Tanaka, Masaru [9 ]
Take, Shunsuke [16 ]
Saito, Shigeru [15 ]
Isshiki, Takaaki [14 ]
Mitsudo, Kazuaki [17 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Tsuchiya Gen Hosp, Hiroshima, Japan
[5] Japanese Red Cross Soc Wakayama Med Ctr, Wakayama, Japan
[6] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan
[7] Hokko Mem Hosp, Sapporo, Hokkaido, Japan
[8] Chikamori Hosp, Kochi, Japan
[9] Osaka Red Cross Hosp, Osaka, Japan
[10] Osaka City Gen Hosp, Osaka, Japan
[11] Natl Hosp Org Kagoshima Med Ctr, Kagoshima, Japan
[12] Nanpuh Hosp, Kagoshima, Japan
[13] Kishiwada Tokushukai Hosp, Kishiwada, Japan
[14] Teikyo Univ Hosp, Tokyo, Japan
[15] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
[16] Saiseikai Noe Hosp, Osaka, Japan
[17] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
关键词
stents; revascularization; coronary disease; ischemia; restenosis; BYPASS-SURGERY; THROMBOSIS; STENOSIS; SURVIVAL;
D O I
10.1161/CIRCULATIONAHA.109.873349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Long-term outcomes after stenting of an unprotected left main coronary artery (ULMCA) with drug-eluting stents have not been addressed adequately despite the growing popularity of this procedure. Methods and Results-j-Cypher is a multicenter prospective registry of consecutive patients undergoing sirolimus-eluting stent implantation in Japan. Among 12 824 patients enrolled in the j-Cypher registry, the unadjusted mortality rate at 3 years was significantly higher in patients with ULMCA stenting (n = 582) than in patients without ULMCA stenting (n = 12 242; 14.6% versus 9.2%, respectively; P < 0.0001); however, there was no significant difference between the 2 groups in the adjusted risk of death (hazard ratio 1.23, 95% confidence interval 0.95 to 1.60, P = 0.12). Among 476 patients whose ULMCA lesions were treated exclusively with a sirolimus-eluting stent, patients with ostial/shaft lesions (n = 96) compared with those with bifurcation lesions (n = 380) had a significantly lower rate of target-lesion revascularization for the ULMCA lesions (3.6% versus 17.1%, P = 0.005), with similar cardiac death rates at 3 years (9.8% versus 7.6%, P = 0.41). Among patients with bifurcation lesions, patients with stenting of both the main and side branches (n = 119) had significantly higher rates of cardiac death (12.2% versus 5.5%; P = 0.02) and target-lesion revascularization (30.9% versus 11.1%; P < 0.0001) than those with main-branch stenting alone (n = 261). Conclusions-The higher unadjusted mortality rate of patients undergoing ULMCA stenting with a sirolimus-eluting stent did not appear to be related to ULMCA treatment itself but rather to the patients' high-risk profile. Although long-term outcomes in patients with ostial/shaft ULMCA lesions were favorable, outcomes in patients with bifurcation lesions treated with stenting of both the main and side branches appeared unacceptable. (Circulation. 2009;120:1866-1874.)
引用
收藏
页码:1866 / U50
页数:16
相关论文
共 50 条
  • [1] Sirolimus-eluting stent implantation for unprotected left main coronary artery disease: One-year outcomes insights from the j-Cypher registry
    Toyofuku, Mamoru
    Hayashi, Yesuhilko
    Mitsudo, Kazuaki
    Morimoto, Takeshi
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B12 - B12
  • [2] Sirolimus-eluting stent implantation for the percutaneous treatment of unprotected left main coronary artery disease: A clinical analysis based on j-Cypher registry
    Toyofuku, Mamoru
    Hayashi, Yasuhiko
    Mitsudo, Kazuaki
    Kimura, Takeshi
    Inoue, Naoto
    Tatami, Ryozo
    Murata, Ren
    CIRCULATION, 2006, 114 (18) : 780 - 780
  • [3] Sirolimus-eluting stent implantation for the percutaneous treatment of unprotected left main coronary artery disease: A clinical analysis based on J-cypher registry
    Toyofuku, Mamoru
    Hayashi, Yesuhiko
    Mitsudo, Kazuaki
    Morimoto, Takeshi
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 218A - 219A
  • [4] Sirolimus-eluting stent implantation for the percutaneous treatment of unprotected left main coronary artery disease: A clinical analysis based on J-cypher registry
    Toyofuku, Momoru
    Hayashi, Yasuhiko
    Mitsudo, Kazuaki
    Kimura, Takeshi
    Inoue, Naoto
    Tatami, Ryozo
    Murata, Ren
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 141M - 141M
  • [5] Sirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Coronary Artery Lesions Three-Year Outcome From the j-Cypher Registry
    Kishi, Koichi
    Kimura, Takeshi
    Morimoto, Takeshi
    Namura, Masanobu
    Muramatsu, Toshiya
    Nishikawa, Hideo
    Hiasa, Yoshikazu
    Isshiki, Takaaki
    Nobuyoshi, Masakiyo
    Mitsudo, Kazuaki
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) : 362 - U127
  • [6] Comparison of 5-Year Outcomes in Patients With and Without Unprotected Left Main Coronary Artery Disease After Treatment With Sirolimus-Eluting Stents Insights From the j-Cypher Registry
    Toyofuku, Mamoru
    Kimura, Takeshi
    Morimoto, Takeshi
    Hayashi, Yasuhiko
    Shiode, Nobuo
    Nishikawa, Hideo
    Nakao, Koichi
    Shirota, Kinya
    Kawai, Kazuya
    Hiasa, Yoshikazu
    Kadota, Kazushige
    Nozaki, Yoichi
    Isshiki, Takaaki
    Sone, Takahito
    Mitsudo, Kazuaki
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (07) : 654 - 663
  • [7] IMPACT OF TOTAL SIROLIMUS-ELUTING STENT LENGTH ON THREE-YEAR CLINICAL OUTCOMES IN THE J-CYPHER REGISTRY
    Shirai, Shinichi
    Kimura, Takeshi
    Nobuyoshi, Masakiyo
    Morimoto, Takeshi
    Ando, Kenji
    Soga, Yoshimitsu
    Yamaji, Kyohei
    Kondo, Katsuhiro
    Sakai, Koyu
    Arita, Takeshi
    Goya, Masahiko
    Iwabuchi, Masashi
    Yokoi, Hiroyoshi
    Nosaka, Hideyuki
    Mitsudo, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] Sirolimus-eluting stent implantation for ostial right coronary artery lesions: five-year outcomes from the j-Cypher registry
    Ko, E.
    Natsuaki, M. N.
    Morimoto, T. M.
    Toyofuku, T. M.
    Tamura, T. T.
    Kimura, T. K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 717 - 718
  • [9] Sirolimus-eluting stent implantation for ostial right coronary artery lesions: Five-year outcomes from the j-Cypher registry
    Ko E.
    Natsuaki M.
    Toyofuku M.
    Morimoto T.
    Matsumura Y.
    Oi M.
    Motohashi Y.
    Takahashi K.
    Kawase Y.
    Tanaka M.
    Kitada M.
    Yuzuki Y.
    Tamura T.
    Inoue K.
    Mitsudo K.
    Kimura T.
    Cardiovascular Intervention and Therapeutics, 2014, 29 (3) : 200 - 208
  • [10] THREE-YEAR CLINICAL OUTCOMES WITH SIROLIMUS-ELUTING STENTS FOR DIABETIC PATIENTS FROM J-CYPHER REGISTRY
    Tada, Tomohisa
    Tamura, Toshihiro
    Mitsudo, Kazuaki
    Kimura, Takeshi
    Morimoto, Takeshi
    Kawamura, Atsushi
    Sone, Takahito
    Nishikawa, Hideo
    Miura, Akira
    Kazatani, Yukio
    Kawasaki, Tomohiro
    Nomura, Masanori
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)